$TMBR 0.14 could be next RS play! Company announced positive opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital Ichthyosis yesterday
I think TMBR need to meet the requirement soon for keep listing~ fits the rs theme!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.